Recent high-quality clinical trial evidence has demonstrated that medications commonly prescribed for migraine prevention in pediatric patients were not superior to placebo for reducing headache symptoms.
All articles by Elizabeth K. Seng, PhD
Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.
Publish Date
-
Latest News Your top articles for Tuesday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses